Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Verano Holdings ( (TSE:VRNO) ) has issued an update.
Verano Holdings has expanded its Florida retail presence with the opening of MÜV Deltona, its fifth dispensary in Volusia County and 83rd in the state, bringing its nationwide dispensary count to 160. The new store, strategically located on a busy Deltona thoroughfare, underscores Verano’s continued push into Florida’s growing medical cannabis market, supported by aggressive promotional offers, recent product launches in fast-growing categories such as multi-pack pre-rolls and therapeutic topicals, and a focus on patient services and digital ordering that strengthens its competitive position and deepens its footprint in a key growth region.
The most recent analyst rating on (TSE:VRNO) stock is a Hold with a C$6.50 price target. To see the full list of analyst forecasts on Verano Holdings stock, see the TSE:VRNO Stock Forecast page.
Spark’s Take on TSE:VRNO Stock
According to Spark, TipRanks’ AI Analyst, TSE:VRNO is a Neutral.
The overall stock score reflects significant challenges in financial performance and technical analysis, with declining revenues, profitability issues, and stagnant price trends. However, positive corporate events provide some optimism for future growth and market expansion. The valuation remains unattractive due to negative earnings and lack of dividends.
To see Spark’s full report on TSE:VRNO stock, click here.
More about Verano Holdings
Verano Holdings Corp. is a vertically integrated, multi-state U.S. cannabis operator with active operations in 13 states, including 160 dispensaries and 15 cultivation and processing facilities totaling more than 1.1 million square feet of cultivation capacity. Through its MÜV and Zen Leaf retail banners and a portfolio of brands such as Verano, MÜV, Savvy, BITS, Encore, (the) Essence and Avexia, the company focuses on regulated medical and adult-use cannabis markets, offering a broad range of flower, edibles, concentrates, vapes, topicals and other cannabinoid-based products.
Technical Sentiment Signal: Sell
Current Market Cap: C$2.17B
See more insights into VRNO stock on TipRanks’ Stock Analysis page.